SQ109, a new drug lead for Chagas disease.

SQ109, a new drug lead for Chagas disease.

Item
http://www.wikidata.org/entity/Q30626912
Tuberculosis therapy for 2016 and beyond.Antibiotics in the clinical pipeline at the end of 2015.Screening the Pathogen Box for Identification of Candida albicans Biofilm InhibitorsAntiinfectives targeting enzymes and the proton motive force.Screening the Medicines for Malaria Venture Pathogen Box across Multiple Pathogens Reclassifies Starting Points for Open-Source Drug Discovery.Inhibition of Leishmania mexicana Growth by the Tuberculosis Drug SQ109Detection and treatment of Trypanosoma cruzi: a patent review (2011-2015).Mechanism of Action of Miltefosine on Leishmania donovani Involves the Impairment of Acidocalcisome Function and the Activation of the Sphingosine-Dependent Plasma Membrane Ca2+ Channel.Looking for combination of benznidazole and Trypanosoma cruzi-triosephosphate isomerase inhibitors for Chagas disease treatment.Bioenergetics of Mycobacterium: An Emerging Landscape for Drug Discovery.
P2860

SQ109, a new drug lead for Chagas disease.

Item
http://www.wikidata.org/entity/Q30626912
description
2015 nî lūn-bûn
@nan
2015 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
SQ109, a new drug lead for Chagas disease.
@ast
SQ109, a new drug lead for Chagas disease.
@en
type
label
SQ109, a new drug lead for Chagas disease.
@ast
SQ109, a new drug lead for Chagas disease.
@en
prefLabel
SQ109, a new drug lead for Chagas disease.
@ast
SQ109, a new drug lead for Chagas disease.
@en
P1433
P1476
P2093
P2860
P304
P31
P356
P407
P433
P478
P50
P577
P5875
P698
P921
P932
P356
P1433
P1476
SQ109, a new drug lead for Chagas disease.
@en
P2093
P2860
P304
P31
P356
P407
P433
P478
P50
P577
P5875
P698
P921
P932